AGENDA

Classifications and prognoses of peripheral T-cell lymphomas
Dan Jones, MD, PhD
University of Texas MD Anderson Cancer Center, Houston, TX

HTLV-1—The viral connection to T-cell lymphomas
Kensei Tobinai, MD, PhD
National Cancer Center Hospital, Tokyo, Japan

Enhancing existing approaches to PTCL
Francine M. Foss, MD
Yale Cancer Center, New Haven, CT

Novel agents in development for PTCL
Owen A. O'Connor, MD, PhD
New York University, New York, NY

High-dose therapy and stem cell transplantation
Pier Luigi Zinzani, MD, PhD
Bologna University, Bologna, Italy

Status of ongoing collaborative efforts
Julie M. Vose, MD
University of Nebraska Medical Center, Omaha, NE

*Faculty disclosures will be provided during the meeting.